Algal Omega-3 — The Vegan Source of EPA and DHA

Algal omega-3 provides direct EPA and DHA, which are incorporated into cell membrane phospholipids to modulate membrane fluidity and receptor function. These fatty acids serve as precursors to specialized pro-resolving mediators (SPMs), including resolvins, protectins, and maresins, which actively resolve acute inflammation. Additionally, EPA and DHA downregulate the NF-κB pathway, reducing the transcription of pro-inflammatory cytokines such as TNF-α and IL-6. DHA is highly concentrated in neuronal membranes, where it supports synaptic plasticity and neuroprotection.

Numerous human trials demonstrate that algal-derived EPA and DHA effectively raise the Omega-3 Index to the same extent as fish oil. Clinical studies show improvements in cardiovascular risk markers, including significant reductions in serum triglycerides and modest lowering of blood pressure. Evidence also supports cognitive benefits in older adults and reduced markers of systemic inflammation.

Typical dosing ranges from 500 to 1,000 mg of combined EPA and DHA per day for general health maintenance. For targeted cardiovascular or triglyceride-lowering effects, doses of 2,000 to 4,000 mg per day are often used. It is best taken with a fat-containing meal to maximize intestinal absorption.

Algal omega-3 is generally well tolerated and avoids the heavy metal contamination risks of fish oil. High doses (exceeding 3–4 grams per day) may modestly increase bleeding risk, particularly in individuals taking anticoagulant or antiplatelet medications. Mild gastrointestinal side effects, such as nausea or loose stools, can occur.

Key Papers